Results 21 to 30 of about 3,957 (191)

Recent Advances in Peripheral Immunoscore in Lung Cancer

open access: yesZhongguo fei ai za zhi = Chinese journal of lung cancer
Lung cancer is the malignant tumor with the highest morbidity and mortality. The tumor-node-metastasis (TNM) staging has gradually shown its limitations in the accurate prediction of lung cancer, so it is urgent to construct a new clinical predictive ...
Zhenyang CHENG   +5 more
core   +4 more sources

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer [PDF]

open access: yes, 2023
Background: The prognostic value of Immunoscore was evaluated in Stage II/III colon cancer (CC) patients, but it remains unclear in Stage I/II, and in early-stage subgroups at risk.
Michal Vocka   +207 more
core   +5 more sources

The Immunoscore: Colon Cancer and Beyond [PDF]

open access: yesClinical Cancer Research, 2020
AbstractTumors evolve in close interaction with their microenvironment, which encompasses a continual tension between the developing tumor and the host immune system. Clinical trials have shown that appropriate enhancement of a tumor immune response can lead to long-lasting clinical responses and patient benefit.
Helen K. Angell   +4 more
openaire   +2 more sources

Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer [PDF]

open access: yesCancers, 2021
Four decades were needed to progress from the first demonstration of the independent prognostic value of lymphocytes infiltration in rectal cancers to the first recommendation from the international guidelines for the use of a standardized immune assay, namely the “Immunoscore” (IS), to accurately prognosticate colon cancers beyond the TNM-system.
El Sissy, Carine   +7 more
openaire   +3 more sources

Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study

open access: yesJournal for ImmunoTherapy of Cancer, 2023
Background Tumor immune cells influence the efficacy of immune-checkpoint inhibitors (ICIs) and many efforts aim at identifying features of tumor immune microenvironment able to predict benefit from ICIs in proficient mismatch repair (pMMR ...
Chiara Cremolini   +20 more
doaj   +1 more source

Tumor-infiltrating lymphocytes and macrophages as a significant prognostic factor in biliary tract cancer.

open access: yesPLoS ONE, 2023
BackgroundThe impact of tumor-infiltrating lymphocytes (TILs) and tumor-associated macrophages (TAMs) on the prognosis of biliary tract cancer (BTC) is not completely understood.
Ryota Tanaka   +9 more
doaj   +2 more sources

Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer. [PDF]

open access: yesMol Oncol
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Dienstmann R   +61 more
europepmc   +2 more sources

Prognostic Value of Immunoscore in Colorectal Carcinomas

open access: yesInternational Journal of Surgical Pathology, 2022
Abstract Background Immunoscore (IS), based on the evaluation of CD3 + and CD8 + densities in the center of the tumor (CT) and its invasive margin (IM), is currently considered as a potential prognostic factor, particularly in colorectal carcinomas (CRC). In the current study, we aimed to assess the prognostic value of IS in CRC stage I to IV,
Helal Imen   +7 more
openaire   +2 more sources

The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life? [PDF]

open access: yesOncotarget, 2022
Because of the function and anatomical environment of the rectum, therapeutic strategies for local advanced rectal cancer (LARC) must deal with two challenging stressors that are a high-risk of local and distal recurrences and a high-risk of poor quality of life (QoL).
Kirilovsky, Amos   +20 more
openaire   +5 more sources

mutation and Immunoscore

open access: yes, 2021
Surgical resection of colorectal liver metastases combined with systemic treatment aims to maximize patient survival. However, recurrence rates are very high postsurgery.
Benoît Navez   +35 more
core   +1 more source

Home - About - Disclaimer - Privacy